Bristol-Myers Squibb Company (BMY)

Net profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net income (ttm)	US$ in thousands	-8,948,000	-7,258,000	-6,541,000	-6,148,000	8,025,000	8,285,000	7,963,000	7,311,000	6,327,000	6,677,000	6,617,000	6,251,000	6,994,000	-5,405,000	-5,079,000	-6,219,000	-9,015,000	-44,000	-563,000	954,000
Revenue (ttm)	US$ in thousands	48,300,000	47,435,000	46,509,000	45,534,000	45,006,000	44,935,000	45,187,000	45,848,000	46,159,000	46,738,000	47,144,000	46,960,000	46,385,000	45,468,000	44,384,000	42,810,000	42,518,000	39,395,000	34,862,000	31,006,000
Net profit margin		-18.53%	-15.30%	-14.06%	-13.50%	17.83%	18.44%	17.62%	15.95%	13.71%	14.29%	14.04%	13.31%	15.08%	-11.89%	-11.44%	-14.53%	-21.20%	-0.11%	-1.61%	3.08%

December 31, 2024 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $-8,948,000K ÷ $48,300,000K
= -18.53%

Bristol-Myers Squibb Company's net profit margin has experienced fluctuations over the given time period from March 31, 2020, to December 31, 2024.

The net profit margin, which represents the percentage of revenue that translates into profit after all expenses have been deducted, started positively at 3.08% on March 31, 2020. However, the company experienced negative net profit margins in the following quarters, with margins dropping to as low as -21.20% by December 31, 2020.

As the analysis progresses, the net profit margin improved significantly, turning positive by December 31, 2021, with a margin of 15.08%. This positive trend continued into the subsequent quarters, reaching a high of 18.44% on September 30, 2023.

However, the net profit margin declined again in the following periods, dropping to -18.53% by December 31, 2024. This downward trend indicates that the company's profitability may have been adversely affected during that specific quarter.

Overall, while the net profit margin of Bristol-Myers Squibb Company has exhibited fluctuations over time, it is important to consider the underlying reasons for these variations to assess the company's financial performance accurately.